Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

The improbable targeted therapy: KRAS as an emerging target in non-small cell lung cancer (NSCLC)

PaperCitations, authors & open-access status

The improbable targeted therapy: KRAS as an emerging target in non-small cell lung cancer (NSCLC) is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 161 citations, 2021 year and gold oa status.

161
Citations
2021
Year
gold
OA Status

Related on ScholarIQ

Isa Mambetsariev
Author
Cell Reports Medicine
Journal
Monoclonal and Polyclonal Antibodies Research
Topic
Monoclonal and Polyclonal Antibodies Research
Topic
Peptidase Inhibition and Analysis
Topic
Lung Cancer Treatments and Mutations
Topic
470M+ articles · free account